Maitreya Medicare Limited IPO: Issue Price, Listing Gain and Share Price Now
Maitreya Medicare Limited listed on 07-Nov-2023 at ₹154.45 against an issue price of ₹82 , a listing gain of +88.35%. It last traded at ₹118.5. This page is the record of that issue and what has happened to it since — reported figures only.
Maitreya Medicare Limited IPO: listing gain and return since
| Measure | Value |
|---|---|
| Issue price | ₹82 |
| Listing price (listing-day close) | ₹154.45 |
| Listing gain | +88.35% |
| Price now | ₹118.5 |
| Change from issue price | +44.51% |
| Change from listing-day close | -23.28% |
The two changes above answer different questions and are routinely opposite in sign. The change from the issue price is what an allottee has made. The change from the listing-day close is what somebody who bought on the first day has made.
Maitreya Medicare Limited IPO details
| Issue term | Detail |
|---|---|
| Issue price (upper band) | ₹82 |
| Issue size | ₹14 Cr |
| Fresh issue | ₹14 Cr |
| Issue opened | 27-Oct-2023 |
| Issue closed | 01-Nov-2023 |
| Listed on | 07-Nov-2023 |
| Exchange | NSE SME |
| Segment | SME |
| Lead managers | GYR Capital (left lead) |
How the Maitreya Medicare Limited IPO was subscribed
| Category | Subscription |
|---|---|
| QIB | 85.41x |
| NII | 744.03x |
| Retail | 509.40x |
| Total | 446.79x |
Maitreya Medicare Limited today
| Figure | Value |
|---|---|
| Market capitalisation | ₹80.3 Cr |
| Return on capital employed | -2.2% |
| Return on equity | -8.9% |
| 52-week high | ₹293 |
| 52-week low | ₹108 |
| Sector | Hospital |
Fundamentals are as of the desk's last harvest and move with the market.
- Maitreya Medicare Limited — full issue page: every stored figure, with its source.
- How many IPOs still trade above their issue price, corporate-action adjusted.
- The full IPO archive: listing gains by year, sector and issue size.
Automated data digest. This page is compiled automatically from exchange filings and public aggregator data. It is a record of reported figures — it is not research, not a recommendation, and not investment advice.
Grey Market Premium (GMP) is an unofficial, unregulated price quoted outside the exchanges. It is not a forecast of the listing price and is frequently wrong.
Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Investments in securities markets are subject to market risk; read all offer documents carefully before investing. Registration granted by SEBI and NISM certification in no way guarantee performance or assure returns.